Patents Assigned to Synapse Pharmaceuticals International, Inc.
  • Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
    Patent number: 6166032
    Abstract: A method for controlling tobacco use and alleviating withdrawal symptoms due to the cessation of tobacco use comprising administering to a human desiring to control tobacco use and/or suffering from withdrawal due to cessation of such use an effective amount of an acetylcholine esterase reactivator or prodrug derivative thereof optionally in association with an acetylcholine receptor antagonist.
    Type: Grant
    Filed: February 7, 1997
    Date of Patent: December 26, 2000
    Assignee: Synapse Pharmaceuticals International, Inc.
    Inventor: Norman Viner
  • Method for treatment of heavy metal poisoning
    Patent number: 5902816
    Abstract: A method is provided for the treatment of heavy metal poisoning in a mammal comprising administering to a mammal including humans suffering from heavy metal poisoning a heavy metal chelating amount of an oxime.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: May 11, 1999
    Assignee: Synapse Pharmaceuticals International, Inc.
    Inventor: Norman M. Viner
  • Method for treatment of obesity
    Patent number: 5900418
    Abstract: A method is provided for the control of obesity comprising administering to a mammal including humans suffering from obesity an acetylcholine esterase reactivator or prodrug derivative thereof optionally in association with an acetylcholine receptor antagonist.
    Type: Grant
    Filed: February 10, 1997
    Date of Patent: May 4, 1999
    Assignee: Synapse Pharmaceuticals International, Inc.
    Inventor: Norman Viner
  • Method for treating drug and alcohol addiction
    Patent number: 5824684
    Abstract: A method for treating treating drug and alcohol addiction comprising administering to a human suffering from such addiction an effective amount of an acetylcholine esterase reactivator.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: October 20, 1998
    Assignee: Synapse Pharmaceuticals International, Inc.
    Inventor: Norman Viner
  • Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
    Patent number: 5760049
    Abstract: A method for controlling tobacco use and alleviating withdrawal symptoms due to the cessation of tobacco use comprising administering to a human desiring to control tobacco use and/or suffering from withdrawal due to tobacco use cessation an acetylcholine receptor antagonist and an acetylcholine esterase reactivator as active ingredients in a pharmaceutically acceptable solid matrix material capable of dissolution and/or disentegration in the mouth or the gastrointestinal tract.
    Type: Grant
    Filed: February 21, 1997
    Date of Patent: June 2, 1998
    Assignee: Synapse Pharmaceuticals International, Inc.
    Inventor: Norman Viner